Emmett Brennan retweeted
✅SGLT2 inhibitor Prescription ⏬
🫡Sick day rule-Stop SGLT2 when pt unwell (fever/vomiting/diarrhea)-Pt education must👍
Emmett Brennan retweeted
Point of Care Ultrasound (POCUS)! Some of the most famous art pieces are designed using the golden spiral...and isn’t POCUS an art too? 🎨❤️
————————————
#pocus #pointofcareultrasound #bedsideecho #echocardiogram #cardiology #ultrasound #goldenspiral #goldencircle #digitalart
Emmett Brennan retweeted
An expert is a person who has made all the mistakes that can be made in a very narrow field.
– Niels Bohr
He represents all of us
30 Years Ago TODAY...
Jack and Paul take you through one of Ireland's greatest ever results 💚
#legend
276
Emmett Brennan retweeted
Takeaways from #ACC2024. Late breaking trials - take home points @ACCinTouch
1. RELIEVE-HF Trial: In patients with HFrEF and HFpEF, Interatrial Shunt did not show any significant difference in the primary effectiveness endpoint, a composite of all-cause mortality, LVAD/heart transplantation, HF hospitalizations, outpatient worsening HF events.
Emmett Brennan retweeted
People with 2 copies of APOE4 have ~10X risk of Alzheimer's. Here's the discovery of a protective variant and learning how fibronectin 1 plays a role
link.springer.com/article/10…
Emmett Brennan retweeted
Recent advances in Cardiology.
(For residents, fellows and professionals in Cardiology)
#CardioTwitter
#cardioEd
All the trials presented at #ACC2024
Emmett Brennan retweeted
Over the last three days, we’ve seen almost all pharmacological strategies presented at #ACC24 fail, including beta blockers, which seemed like the only certainty. On the contrary, if we are to believe in the results we've seen, we should start using more microaxial flow pump devices in STEMI-related cardiogenic shock, doing PCI in vulnerable plaques, and TAVI in low-risk patients. Perhaps a bit too much excitement for interventionalists all at once, wasn't it better to distribute it a bit more throughout the year?
Emmett Brennan retweeted
ULTIMATE DAPT trial showed in pts with ACS treated with PCI, ticagrelor monotherapy btw 1 and 12 months decreased clinically-relevant and major bleeding, had similar protection from MACCE vs DAPT (ticagrelor + aspirin).
Fascinating session making a case for restructuring the guidelines for High Risk PE based on evolving catheter based options and mechanical support. Systemic thrombolysis study enrolled 8 patients -> class 1b recommendation. ……Wild. #ACC2024
4
227
Emmett Brennan retweeted
Presented today at #ACC24:
In the DanGer Shock trial involving patients with STEMI and cardiogenic shock, mortality at 6 months was lower with mechanical circulatory support with a microaxial flow pump than with standard care alone. Full trial results: nej.md/3xyXU3t
Emmett Brennan retweeted
My challenge to everyone attending #ACC24: You are investing a lot of time/money to be there - find a way to get a 10x return on that investment.
How? See 🧵below for a few ideas. @ACCinTouch @ACCMaryland @nbwiggins @noshreza @T_GuptaMD @Adam_Kisling @KBerlacher @DougDrachmanMD
Emmett Brennan retweeted
Gearing up for Heart Failure Awareness Week 2024❣️
Join our Residents on February 14th, 2024 to talk about Heart Failure🫀
@MitchellHare @EBrennan9 @VictorFSMD @fjamadorc @Henryaiwuyo1 @NikolaS11775830 @AdarshGBalaji @ProfdotOlayemi @kikibebz – at Brooklyn, NY
Emmett Brennan retweeted
Really nice new paper in @JACCJournals led by @StanSwatMD @kofi_larry on reasons for nonintensification of indicated GDMT in outpatients with HFrEF
Should dedicated “GDMT” clinics (PharmD/APN/MD) be established with the purpose being to ⬇️ inertia?
📎 tinyurl.com/y6syewns
Emmett Brennan retweeted
Major Study including >1 million patients from 24 US centers demonstrating the mortality burden of the different degrees of severity of aortic stenosis. And with an editorial from the godfather of AS Dr. E. Braunwald!
pubmed.ncbi.nlm.nih.gov/3787…
Emmett Brennan retweeted
What should you call that elevated troponin?
This is NOT taught well and impacts more than you think.
Understand it in 2 minutes:





































